Dramatic HHS cuts leave US ‘weaker as a nation,’ says top FDA vaccine official forced out under Kennedy
Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...
MPR17h
FDA Drug Approval Decisions Expected in May 2025
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
A live webcast of the fireside chat will be available on the Events and Presentations section of Palvella's website at www.palvellatx.com. An archived replay of the webcast will be available for ...
Amgen gets expanded FDA label approval for Uplizna
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
Amgen announces FDA approval of Uplizna
Amgen (AMGN) announced that the U.S. FDA has approved Uplizna as the first and only treatment for adults living with Immunoglobulin G4-related ...
Endovascular Today1d
FDA Approves New Large-Diameter Tapered Designs of Gore TAG Conformable Thoracic Stent Graft
Gore & Associates recently announced an expansion of the Gore TAG conformable thoracic stent graft with Active Control system ...
US FDA Approves Amgen's Uplizna as First Treatment for Rare Immune Disorder
The drug, also known as inebilizumab, has now become the first FDA-approved treatment for Immunoglobulin G4-related disease ...
FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
US Supreme Court largely backs FDA's denial of flavored vape product applications
The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette ...
Gastroenterology Advisor2d
FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures
The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.